February 14, 2018

Farmington biotech lands $1.1M equity investment

Farmington-based startup Shoreline Biome said it has secured $1.1 million in equity funding from Connecticut Innovations and other investors to continue developing its kits and other technology that identify and quantify bacteria in the human microbiome.

The company, located at the UConn Technology Incubation Program (TIP) on the UConn Health campus, collaborates with faculty from The Jackson Laboratory for Genomic Medicine, Yale University and UConn. Shoreline Biome joined TIP in 2015. The company says its tools are advancing understanding how the human microbiome functions across the entire landscape of human health and disease.

Tom Jarvie, Shoreline Biome's CEO, said the company's analysis provides a quick view of organisms present in samples and allows researchers to "process 96 samples in the morning and have them ready for DNA sequencing after lunch."

Both Jarvie and his fellow co-founder Mark Driscoll previously worked for DNA sequencing provider 454 Life Sciences in Branford, which Roche acquired in 2007 for about $155 million but shuttered in 2013.

Free E-Newsletters

Sign up now for our daily and weekly
e-newsletters! Click Here

Today's Poll Should the state legislature adopt paid family medical leave?<>
Most Popular on Facebook
Copyright 2017 New England Business Media